Annual Operating Expenses
$85.94 M
+$31.23 M+57.08%
December 31, 2023
Summary
- As of February 8, 2025, LPTX annual total operating expenses is $85.94 million, with the most recent change of +$31.23 million (+57.08%) on December 31, 2023.
- During the last 3 years, LPTX annual operating expenses has risen by +$56.13 million (+188.31%).
- LPTX annual operating expenses is now at all-time high.
Performance
LPTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$18.35 M
-$2.65 M-12.60%
September 30, 2024
Summary
- As of February 8, 2025, LPTX quarterly total operating expenses is $18.35 million, with the most recent change of -$2.65 million (-12.60%) on September 30, 2024.
- Over the past year, LPTX quarterly operating expenses has increased by +$3.51 million (+23.65%).
- LPTX quarterly operating expenses is now -56.77% below its all-time high of $42.45 million, reached on March 31, 2023.
Performance
LPTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LPTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.1% | +23.6% |
| 3 y3 years | +188.3% | -56.8% |
| 5 y5 years | +186.5% | -56.8% |
LPTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +106.1% | -56.8% | +73.2% |
| 5 y | 5-year | at high | +188.3% | -56.8% | +175.1% |
| alltime | all time | at high | +876.7% | -56.8% | +346.3% |
Leap Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.35 M(-12.6%) |
| Jun 2024 | - | $21.00 M(+44.0%) |
| Mar 2024 | - | $14.58 M(-1.8%) |
| Dec 2023 | $85.94 M(+57.1%) | $14.84 M(+3.9%) |
| Sep 2023 | - | $14.28 M(-0.6%) |
| Jun 2023 | - | $14.36 M(-66.2%) |
| Mar 2023 | - | $42.45 M(+222.4%) |
| Dec 2022 | $54.71 M(+31.2%) | $13.17 M(-10.0%) |
| Sep 2022 | - | $14.64 M(-10.3%) |
| Jun 2022 | - | $16.31 M(+54.0%) |
| Mar 2022 | - | $10.60 M(-5.6%) |
| Dec 2021 | $41.70 M(+39.9%) | $11.22 M(-0.2%) |
| Sep 2021 | - | $11.25 M(+15.3%) |
| Jun 2021 | - | $9.76 M(+3.0%) |
| Mar 2021 | - | $9.48 M(+24.0%) |
| Dec 2020 | $29.81 M(-10.5%) | $7.64 M(-0.2%) |
| Sep 2020 | - | $7.66 M(-2.4%) |
| Jun 2020 | - | $7.84 M(+17.5%) |
| Mar 2020 | - | $6.67 M(-19.3%) |
| Dec 2019 | $33.32 M(+11.1%) | $8.27 M(+4.3%) |
| Sep 2019 | - | $7.93 M(-5.6%) |
| Jun 2019 | - | $8.40 M(-3.7%) |
| Mar 2019 | - | $8.72 M(-7.3%) |
| Dec 2018 | $30.00 M | $9.40 M(+13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $8.30 M(+25.9%) |
| Jun 2018 | - | $6.59 M(+15.7%) |
| Mar 2018 | - | $5.70 M(-14.7%) |
| Dec 2017 | $30.64 M(+26.7%) | $6.68 M(-12.3%) |
| Sep 2017 | - | $7.62 M(+16.9%) |
| Jun 2017 | - | $6.52 M(-33.5%) |
| Mar 2017 | - | $9.81 M(+104.0%) |
| Dec 2016 | $24.18 M(+102.8%) | $4.81 M(-31.6%) |
| Sep 2016 | - | $7.03 M(-2.3%) |
| Jun 2016 | - | $7.19 M(+39.9%) |
| Mar 2016 | - | $5.14 M(-169.0%) |
| Dec 2015 | $11.92 M(-43.0%) | -$7.45 M(-229.4%) |
| Sep 2015 | - | $5.76 M(-14.7%) |
| Jun 2015 | - | $6.75 M(-1.6%) |
| Mar 2015 | - | $6.86 M(-9.0%) |
| Dec 2014 | $20.92 M(+50.8%) | $7.54 M(+33.8%) |
| Sep 2014 | - | $5.63 M(+28.4%) |
| Jun 2014 | - | $4.39 M(+30.9%) |
| Mar 2014 | - | $3.35 M(-13.0%) |
| Dec 2013 | $13.87 M(+57.6%) | $3.85 M(-28.3%) |
| Sep 2013 | - | $5.38 M(+131.9%) |
| Jun 2013 | - | $2.32 M(+0.2%) |
| Mar 2013 | - | $2.32 M |
| Dec 2012 | $8.80 M | - |
FAQ
- What is Leap Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Leap Therapeutics?
- What is Leap Therapeutics annual operating expenses year-on-year change?
- What is Leap Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Leap Therapeutics?
- What is Leap Therapeutics quarterly operating expenses year-on-year change?
What is Leap Therapeutics annual total operating expenses?
The current annual operating expenses of LPTX is $85.94 M
What is the all time high annual operating expenses for Leap Therapeutics?
Leap Therapeutics all-time high annual total operating expenses is $85.94 M
What is Leap Therapeutics annual operating expenses year-on-year change?
Over the past year, LPTX annual total operating expenses has changed by +$31.23 M (+57.08%)
What is Leap Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of LPTX is $18.35 M
What is the all time high quarterly operating expenses for Leap Therapeutics?
Leap Therapeutics all-time high quarterly total operating expenses is $42.45 M
What is Leap Therapeutics quarterly operating expenses year-on-year change?
Over the past year, LPTX quarterly total operating expenses has changed by +$3.51 M (+23.65%)